06/05/14	Actavis : Factbox - M&A frenzy transforming global pharma	RE
06/05/14	Actavis : M&A frenzy in healthcare sector	RE
14/04/14	Actavis : Investors support deals spree, happy to see U.S. companies buy growth	RE
10/04/14	Icahn backs down from demand that eBay spin off PayPal	RE
20/02/14	Suntory Beverage & Food Ltd : Goldman Sachs misses out on WhatsApp, 2014's top deals so far	RE
19/02/14	Icahn says Actavis-Forest deal validates shareholder activism	RE
18/02/14	Actavis to buy Forest for $25 billion; windfall for investor Icahn	RE
18/02/14	Actavis PLC : Actavis to buy Forest for $25 billion; windfall for investor Icahn	RE
18/02/14	Actavis PLC : Actavis in talks to buy Forest Labs for as much as $25 billion - WSJ	RE
09/01/14	S&P 500 ends flat in wake of Fed minutes	RE
08/01/14	Forest Laboratories, Inc. : Forest Labs to buy Aptalis from TPG for $2.9 billion	RE
08/01/14	Evercore Partners Inc. : Forest Labs nears $3 billion deal for Aptalis - source	RE
23/10/13	Elan Corporation, plc : Exclusive - TPG-backed Aptalis Pharma hires banks for an IPO: sources	RE

01/07/14	Forest Laboratories : Actavis and Forest Receive U.S. FTC Clearance for Actavis’ Proposed Acquisition of Forest	BU
30/06/14	Forest Laboratories : Actavis and Forest Announce Preliminary Stockholder Merger Consideration Election Results	BU
23/06/14	Forest Laboratories : Announces Positive Topline Results from Three Phase III Trials for Vilazodone in the Treatment of Generalized Anxiety Disorder (GAD)	BU
23/06/14	Forest Laboratories : Actavis and Forest Laboratories Announce Appointment of C. David Nicholson, PhD to lead Actavis Global Brands Research and Development	BU
20/06/14	Forest Laboratories : to Present Cariprazine Data at the International College of Neuropsychopharmacology World Congress	BU

News in other languages: Forest Laboratories, Inc.

17/11/16	Devisen: Euro fällt zum USD weiter - Hinweise auf US-Zinserhöhung belasten
28/04/14	Bank of America : Wall Street ouvre en hausse, les pharmaceutiques en vue
28/04/14	Wall Street ouvre en hausse, les pharmaceutiques en vue
28/04/14	Actavis : Forest Laboratories achète Furiex pour 1,46 milliard de dollars
28/04/14	Forest Laboratories : Pharmacie-Forest achète Furiex pour $1,46 milliard

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ELI LILLY AND COMPANY	+2.16%	+3.17%	+43.57%	+160.28%	1,035B
JOHNSON & JOHNSON	-0.07%	+4.45%	+53.50%	+48.95%	574B
ABBVIE INC.	-0.08%	-0.08%	+17.37%	+62.66%	397B
ROCHE HOLDING AG	+0.77%	+0.77%	+21.19%	+15.95%	324B
ASTRAZENECA PLC	+0.85%	+0.18%	+24.50%	+15.93%	281B
NOVARTIS AG	+2.10%	+4.92%	+25.30%	+34.79%	278B
NOVO NORDISK A/S	-0.19%	-0.46%	-45.32%	-48.23%	193B
AMGEN INC.	+4.84%	+2.45%	+21.33%	+61.85%	191B
GILEAD SCIENCES, INC.	+3.61%	-2.56%	+15.16%	+61.12%	156B
Average	+1.55%	+1.68%	+19.62%	+45.92%	381.1B
Weighted average by Cap.	+1.37%	+2.39%	+29.50%	+72.97%